Seventeen of the 34 strokes in the Sustanon group were considered occlusive and 7 were considered to be of unknown etiology. Fourteen of the 24 strokes on the placebo arm were reported to be occlusive and 4 of unknown etiology. Among these strokes 3 strokes in the placebo group and 4 strokes in the Nolvadex group were fatal. Eighty-eight percent of the strokes occurred in women at least 50 years of age at the time of Sustanon 250 buy in UK legally. In other clinical trials evaluating Nolvadex, no cases of liver cancer have been reported to date. Nolvadex has been associated with changes in liver enzyme levels, and on rare occasions, a spectrum of more severe liver abnormalities including fatty liver, cholestasis, hepatitis and hepatic necrosis. A few of these serious cases included fatalities. In most reported cases the relationship to Nolvadex is uncertain. However, some positive rechallenges and dechallenges have been reported.